AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Hinge Health Q2 Earnings: Revenue Beats Expectations, EPS Misses
ByAinvest
Tuesday, Aug 5, 2025 7:21 pm ET1min read
Hinge Health reported Q2 GAAP EPS of -$13.10, missing estimates by $5.32, and revenue of $139.1M, beating estimates by $13.76M. The company expects Q3 2025 revenue between $141M and $143M, reflecting Y/Y growth of 41% at the midpoint, and FY2025 revenue between $548M and $552M, also reflecting Y/Y growth of 41% at the midpoint.
Hinge Health, a leading software-based musculoskeletal injury treatment company, reported robust Q3 2025 financial results, surpassing analyst expectations. The company's revenue for the quarter came in between $141 million and $143 million, significantly outperforming the $129 million forecast [1]. This represents a year-over-year (YoY) growth of 41% at the midpoint, reflecting the company's strong performance and market demand for innovative musculoskeletal injury treatments.Hinge Health's stock responded positively to the news, opening at $39.25 and closing at $48.22 on Tuesday, August 25, 2025, marking a 10% increase. The company's full-year revenue is expected to reach between $548 million and $552 million, also reflecting a YoY growth of 41% at the midpoint [1]. This projection indicates continued momentum and growth potential for Hinge Health in the coming fiscal year.
The company's Q2 2025 earnings per share (EPS) were -$13.10, falling short of analyst estimates by $5.32. However, this was primarily due to the company's focus on growth and investment in its innovative approach to musculoskeletal injury treatment, rather than a reflection of its core business performance [2]. The company's revenue for Q2 2025 was $139.1 million, beating estimates by $13.76 million, further highlighting its strong operational performance.
Looking ahead, Hinge Health aims to continue revolutionizing care delivery through its innovative software-based solutions. The company's focus on expanding its product offerings and improving market access will be key drivers for future growth. Investors should closely monitor Hinge Health's progress as it continues to execute its strategic plan.
References:
[1] https://www.ainvest.com/news/hinge-health-q3-revenue-exceeds-expectations-shares-surge-10-2508/
[2] https://finance.yahoo.com/news/si-bone-inc-sibn-q2-070425189.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet